http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08217792-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-113 |
| filingDate | 1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4142904730c75d1ea884f7b73d8aa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0054648967ac0ea3248bcd6f07eca218 |
| publicationDate | 1996-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08217792-A |
| titleOfInvention | Bioactive peptide |
| abstract | (57) [Summary] [PROBLEMS] To provide a novel physiologically active peptide, particularly a physiologically active peptide having a platelet-derived growth factor (PDGF) inhibitory action. [Structure] The following formula [I] A-Ya-Xa-Yb-Xb-Yc-Xc-Yd-B ... [I] [In the formula, A is a hydrogen atom, an acyl group having 1 to 7 carbon atoms, and a carbon number. 1 to 8 is an amino-terminal residue selected from alkoxycarbonyl groups, Xa represents one amino acid residue, Xb represents an L- or D-tryptophan residue or a chemically modified L- or D-tryptophan residue, Xc represents one amino acid residue, and Ya, Yb, Y Any one of c and Yd is L-cysteine and the other three represent a bond, B is a hydroxyl group, and 1 to 1 carbon atoms. 7 is a carboxy terminal residue selected from an alkoxy group, an amino group, and a mono- or dialkylamino group having 1 to 7 carbon atoms] |
| priorityDate | 1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.